1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA REPS1 CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA HMGN3 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA ATAT1 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA DRAP1 CTRPv2 pan-cancer AAC -0.16 2e-06
mRNA USP49 CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA IP6K2 CTRPv2 pan-cancer AAC 0.16 2e-06
mRNA PIKFYVE CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA NUP58 CTRPv2 pan-cancer AAC 0.15 2e-06
mRNA C4orf46 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA UBQLN2 CTRPv2 pan-cancer AAC 0.15 2e-06
Download CSV